Only 33 HCC patients (30.5%) could be diagnostically identified by AFP levels, while C16Cer and S1P were able to identify additional 72 (67.5%) and 70 (64.8%) HCC patients respectively (Supplementary Figure 4A, 4C). Here, AFP is linked to hepatocellular carcinoma.